NCT03002571View on ClinicalTrials.gov

Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects (301)

PHASE3CompletedINTERVENTIONAL

Enrollment

338

Participants

Timeline

Start Date

July 24, 2018

Primary Completion Date

April 14, 2020

Study Completion Date

April 14, 2020

Conditions

Atopic Dermatitis

Interventions

DRUG

IDP-124 Lotion

IDP-124 Lotion, twice-daily application

DRUG

IDP-124 Vehicle Lotion

IDP-124 Vehicle Lotion, twice-daily application

Trial Locations (1)

33305

Valeant Site 01, Fort Lauderdale

All Listed Sponsors

lead

Bausch Health Americas, Inc.

INDUSTRY

NCT03002571 - Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects (301) | Biotech Hunter | Biotech Hunter